Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 13/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.39 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.39 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16634781 | 0.81 | RORC (0.55) | RORCCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16634733 | 0.76 | RORC (0.46) | RORCCYP3A4CYP2C9 | |
| SCHEMBL16634638 | 0.76 | RORC (0.50) | RORCCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16634596 | 0.75 | RORC (0.61) | RORCCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16634653 | 0.74 | RORC (0.60) | RORCCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16634773 | 0.74 | RORC (0.48) | RORCCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16634761 | 0.73 | RORC (0.58) | RORCCYP3A4CYP2C9 | |
| SCHEMBL16968669 | 0.71 | RORC (1.00) | RORCCYP3A4 | |
| SCHEMBL16634752 | 0.70 | RORC (0.56) | RORCCYP3A4CYP2C9CYP2C19 | |
| SCHEMBL16634943 | 0.69 | RORC (0.48) | RORCCYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015052675-A1 | SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2015-04-16 | — | — | WO | disclosed |